Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Days Sales Outstanding

: 69.54 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

Teva Pharmaceutical Industries's average Accounts Receivable for the three months ended in Dec. 2023 was $3,397 Mil. Teva Pharmaceutical Industries's Revenue for the three months ended in Dec. 2023 was $4,457 Mil. Hence, Teva Pharmaceutical Industries's Days Sales Outstanding for the three months ended in Dec. 2023 was 69.54.

The historical rank and industry rank for Teva Pharmaceutical Industries's Days Sales Outstanding or its related term are showing as below:

TEVJF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 80.45 Med: 105.98 Max: 129.35
Current: 80.45

During the past 13 years, Teva Pharmaceutical Industries's highest Days Sales Outstanding was 129.35. The lowest was 80.45. And the median was 105.98.

TEVJF's Days Sales Outstanding is ranked worse than
58.9% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.185 vs TEVJF: 80.45

Teva Pharmaceutical Industries's Days Sales Outstanding declined from Dec. 2022 (87.26) to Dec. 2023 (69.54).

Teva Pharmaceutical Industries Days Sales Outstanding Historical Data

The historical data trend for Teva Pharmaceutical Industries's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

124.26

112.37

104.70

100.57

81.82

Teva Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																87.26	88.85	82.07	82.05	69.54

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Days Sales Outstanding falls into.

Teva Pharmaceutical Industries Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Teva Pharmaceutical Industries's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3696	+	3408)	/	2 )	/	15845	*	365
=	3552					/	15845	*	365
=	81.82

Teva Pharmaceutical Industries's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3385	+	3408)	/	2 )	/	4457	*	365 / 4
=	3396.5					/	4457	*	365 / 4
=	69.54

Teva Pharmaceutical Industries (OTCPK:TEVJF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Teva Pharmaceutical Industries Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (OTCPK:TEVJF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.